This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Dart Therapeutics LLC, Galapagos Nv. Active years: 2011-2013.
Company Filing History:
Years Active: 2011-2013
Title: Roland Blanqué: Innovator in Pharmaceutical Compounds
Introduction
Roland Blanqué is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that serve as androgen receptor modulators. With a total of 2 patents, his work has the potential to impact various medical conditions.
Latest Patents
Blanqué's latest patents focus on imidazolidine compounds that act as androgen receptor modulators. These novel compounds are designed to be prepared as pharmaceutical compositions. They may be utilized for the prevention and treatment of a variety of conditions in mammals, including humans. Some of the conditions addressed by these compounds include cachexia, osteoporosis, sarcopenia, a decline in libido, and sexual dysfunction.
Career Highlights
Throughout his career, Roland Blanqué has worked with prominent companies in the pharmaceutical industry. Notable among these are Galapagos NV and Dart Therapeutics LLC. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Blanqué has collaborated with several professionals in his field, including Catherine Jagerschmidt and Florence Sylvie Namour. These collaborations have likely enriched his research and development efforts.
Conclusion
Roland Blanqué is a distinguished inventor whose work in pharmaceutical compounds holds promise for addressing significant health issues. His contributions to the field are noteworthy and reflect his commitment to innovation in medicine.